Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|May 27, 2005
Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agentsAyako Yawata, Su-Ryang Kim, Atsuko Miyajima, et al.
Toxicology|November 13, 2012
Toxicogenomic biomarkers for renal papillary injury in ratsTakeki Uehara, Chiaki Kondo, Yuji Morikawa, et al.
The Journal of Toxicological Sciences|October 30, 2007
Current opinion: safety evaluation of drug metabolites in development of pharmaceuticalsShinsaku Naito, Shigeru Furuta, Takemi Yoshida, et al.
Toxicology and Applied Pharmacology|July 26, 2011
Prediction model of potential hepatocarcinogenicity of rat hepatocarcinogens using a large-scale toxicogenomics databaseTakeki Uehara, Yohsuke Minowa, Yuji Morikawa, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 3, 2008
Decreased expression of cytochromes P450 1A2, 2E1, and 3A4 and drug transporters Na+-taurocholate-cotransporting polypeptide, organic cation transporter 1, and organic anion-transporting peptide-C correlates with the progression of liver fibrosis in chronic hepatitis C patientsKenya Nakai, Hiromasa Tanaka, Kazuhiko Hanada, et al.
The Journal of Toxicological Sciences|August 2, 2008
Safety assessment of biopharmaceuticals: Japanese perspective on ICH S6 guideline maintenanceTakahiro Nakazawa, Misao Kurokawa, Kazuya Kimura, et al.
Journal of Applied Toxicology : JAT|June 15, 2012
Establishment and intra-/inter-laboratory validation of a standard protocol of reactive oxygen species assay for chemical photosafety evaluationSatomi Onoue, Kazuhiro Hosoi, Shinobu Wakuri, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 22, 2005
Functional characterization of three naturally occurring single nucleotide polymorphisms in the CES2 gene encoding carboxylesterase 2 (HCE-2)Takashi Kubo, Su-Ryang Kim, Kimie Sai, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2019
Peptide vaccinations elicited strong immune responses that were reboosted by anti-PD1 therapy in a patient with myxofibrosarcomaTomohide Tsukahara, Kazue Watanabe, Kenji Murata, et al.
The Journal of Toxicological Sciences|December 7, 2018
Comparative assessment of 24-hr primary skin irritation test and human patch test data with in vitro skin irritation tests according to OECD Test Guideline 439 (for quasi-drugs in Japan)Mariko Sugiyama, Masaharu Akita, Nathalie Alépée, et al.
Pageof 11